|
Name |
2,3-Dimethyl-2-cyclopenten-1-one
|
| Molecular Formula | C7H10O | |
| IUPAC Name* |
2,3-dimethylcyclopent-2-en-1-one
|
|
| SMILES |
CC1=C(C(=O)CC1)C
|
|
| InChI |
InChI=1S/C7H10O/c1-5-3-4-7(8)6(5)2/h3-4H2,1-2H3
|
|
| InChIKey |
UZLQSPYGTUMKGS-UHFFFAOYSA-N
|
|
| Synonyms |
2,3-Dimethyl-2-cyclopenten-1-one; 1121-05-7; 2,3-Dimethylcyclopent-2-en-1-one; 2-Cyclopenten-1-one, 2,3-dimethyl-; 2,3-DIMETHYL-2-CYCLOPENTENONE; Y6A4YU4DWN; 2,3-dimethylcyclopent-2-enone; dimethylcyclopentenone; 2-Cyclopenten-1-one,2,3-dimethyl-; UNII-Y6A4YU4DWN; SCHEMBL161507; 2,3-Dimethyl-cyclopent-2-enone; DTXSID80149901; ZINC2039884; 2,3-dimethyl-cyclopent-2-en-1-one; 2,3-Dimethylcyclopenta-2-en-1-one; AKOS015912514; 2,3-Dimethyl-2-cyclopenten-1-one #; Cyclopent-2-en-1-one, 2,3-dimethyl; 2,3-Dimethyl-2-cyclopenten-1-one, 99%; CS-0253128; EN300-62493; J-002707; Q63395351
|
|
| CAS | 1121-05-7 | |
| PubChem CID | 14270 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 110.15 | ALogp: | 0.8 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 1 |
| Heavy Atoms: | 8 | QED Weighted: | 0.467 |
| Caco-2 Permeability: | -4.429 | MDCK Permeability: | 0.00002860 |
| Pgp-inhibitor: | 0.023 | Pgp-substrate: | 0.014 |
| Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.023 |
| 30% Bioavailability (F30%): | 0.004 |
| Blood-Brain-Barrier Penetration (BBB): | 0.977 | Plasma Protein Binding (PPB): | 56.61% |
| Volume Distribution (VD): | 0.767 | Fu: | 62.01% |
| CYP1A2-inhibitor: | 0.653 | CYP1A2-substrate: | 0.833 |
| CYP2C19-inhibitor: | 0.252 | CYP2C19-substrate: | 0.873 |
| CYP2C9-inhibitor: | 0.035 | CYP2C9-substrate: | 0.661 |
| CYP2D6-inhibitor: | 0.163 | CYP2D6-substrate: | 0.621 |
| CYP3A4-inhibitor: | 0.014 | CYP3A4-substrate: | 0.305 |
| Clearance (CL): | 9.626 | Half-life (T1/2): | 0.828 |
| hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.029 |
| Drug-inuced Liver Injury (DILI): | 0.125 | AMES Toxicity: | 0.012 |
| Rat Oral Acute Toxicity: | 0.208 | Maximum Recommended Daily Dose: | 0.097 |
| Skin Sensitization: | 0.279 | Carcinogencity: | 0.31 |
| Eye Corrosion: | 0.931 | Eye Irritation: | 0.989 |
| Respiratory Toxicity: | 0.194 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002343 | ![]() |
0.500 | D0Z8AA | ![]() |
0.222 | ||
| ENC001840 | ![]() |
0.421 | D0N0OU | ![]() |
0.205 | ||
| ENC001459 | ![]() |
0.421 | D0Z8SF | ![]() |
0.200 | ||
| ENC004598 | ![]() |
0.362 | D00EEL | ![]() |
0.190 | ||
| ENC005199 | ![]() |
0.356 | D0H6VY | ![]() |
0.188 | ||
| ENC005114 | ![]() |
0.311 | D0K7LU | ![]() |
0.186 | ||
| ENC005198 | ![]() |
0.291 | D00IUG | ![]() |
0.179 | ||
| ENC002195 | ![]() |
0.269 | D0S5CH | ![]() |
0.179 | ||
| ENC001280 | ![]() |
0.265 | D00ETS | ![]() |
0.175 | ||
| ENC005108 | ![]() |
0.265 | D0Q4XQ | ![]() |
0.175 | ||